Phenex Pharmaceuticals AG’s presentation at the AASLD The Liver Meeting® 2018 in San Francisco.

News Release 2018.11.14

SMC announced that Phenex Pharmaceuticals AG presented results of a study using STAM model at poster presentation at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2018 in San Francisco, November 9 -13.

Title: “Unexpected Antidiabetic Effects Combined with Antifibrotic Activities of LXR inverse Agonists in Mouse Models of NAFLD/Nash”